Compare MLCI & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MLCI | YI |
|---|---|---|
| Founded | N/A | 2010 |
| Country | United States | China |
| Employees | 21 | N/A |
| Industry | Investment Managers | Retail-Drug Stores and Proprietary Stores |
| Sector | Finance | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.6M | 57.1M |
| IPO Year | N/A | 2018 |
| Metric | MLCI | YI |
|---|---|---|
| Price | $3.45 | $6.30 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 70.8K | 14.7K |
| Earning Date | 03-13-2026 | 03-20-2026 |
| Dividend Yield | ★ 3.31% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.55 | $2.48 |
| 52 Week High | $8.68 | $11.17 |
| Indicator | MLCI | YI |
|---|---|---|
| Relative Strength Index (RSI) | 20.48 | 39.82 |
| Support Level | N/A | $6.13 |
| Resistance Level | $8.06 | $6.86 |
| Average True Range (ATR) | 0.35 | 0.47 |
| MACD | -0.11 | -0.09 |
| Stochastic Oscillator | 2.86 | 21.10 |
Mount Logan Capital Inc operates as emerging asset management and investment firm focused on investing in public and private debt securities in the North American market. The Company's reporting segments include asset management and insurance. The asset management segment reflects the Company's historical operations through its subsidiaries, including ML Management, and the insurance segment represents Ability's operations. The Company through its subsidiaries, earns management and incentive fees and servicing fees for providing investment management, monitoring and other services to investment vehicles and advisers. The insurance business is operated by Ability. Ability's insurance business consists of premium revenue from long term care insurance policies.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.